Keep up to date on the latest medical news at MDLinx - FREE!

  • Stay current on the latest medical literature, research and clinical news
  • MD jobs and physician job search at our new medical job Career Center
  • Receive invitations to paid market research
  • Search Clinical Trials and Medical Conferences

register to view free medical at articles at MDLinx

Follow Us

Posts by category

MDLinx Blog - Medical News and more.

Current Articles | RSS Feed RSS Feed

Update on M3 Global Research Operations in Japan


We at M3 USA & MDLinx would like to thank everyone for your expressions of concern and best wishes regarding the safety of our team in Japan.  We are happy to report that at this time the entire M3 team of 172 Tokyo employees is safe. Our executive team in Japan is shifting work around the world to allow continuous operations as staff tend to their families and friends.

We appreciate that your projects are important and that you have deadlines to meet. M3 will do everything that we can to help you do so. However, we would like to remind you that the Japanese research “sample” and “responders” are people who are climbing out of their worst disaster in 2  generations. Our team in Japan, along with those Professional Healthcare providers who participate in market research, are extending themselves and their resources in order to assist their fellow countrymen as much as possible. With this in mind, we will not be initiating any projects in Japan over the next week.  This pause in fieldwork will be reviewed on a daily basis and modified as necessary depending on the progress of the recovery process.  We also hope you understand that it will be some time before normal business resumes for our industry in Japan and until further notice we will be doubling our time in field for all projects.

Tokyo and other cities countrywide will be experiencing planned and rolling blackouts in order to provide electricity for the hardest hit areas. This will significantly affect all commuting travel, especially train arrivals and departures, and will require modification of regular office hours. Please note as well that Prefectures such as Fukushima (among others) will have greatly diminished capacity for survey participation, affecting about 6% of our universe.  Be assured we will continue to work as diligently as was always have and do everything we can to complete current and future projects for Japan.

Finally, if you are interested in assisting those affected in Japan, the Red Cross is accepting donations on their behalf.

Thank you again for your thoughts and concerns as we along with you pray for everyone affected by the multiple tragedies in Japan.

Trending Medical Articles

Monday, Mar 31, 2014
Journal of Oral Implantology, 03/31/2014 Nayak AG, et al. – Gaps and hollow spaces at the implant abutment interface will act as a bacterial reservoir that may cause peri–implantitis. Hence, the sealing ability of O–ring (in addition to polysiloxane) and GapSeal (an antibacterial sealing gel) was evaluated. The data thus obtained were subjected to statistical analysis by...Read More
Tuesday, Apr 8, 2014
Annals of Rheumatic Diseases, 04/08/2014 Saevarsdottir S, et al. – To study clinical predictors for radiographic progression after 1 year in an early rheumatoid arthritis (RA) trial. In addition to previously described predictors, the authors identified smoking as a strong independent risk factor for radiographic progression in early RA. Methods In the SWEFOT trial population, disease...Read More
Monday, Apr 7, 2014
Physiotherapy, 04/07/2014 Spencer LM, et al. – The aim of this study is to determine if there was an increase in walk distance when two incremental shuttle walk tests (ISWTs) were performed at the commencement of a maintenance exercise program and at three, six and 12–month assessments. The increase in walk distance when a second ISWT was performed at zero and three months...Read More
Tuesday, Apr 15, 2014
Breast Cancer Research and Treatment, 04/15/2014 Guha P, et al. – The authors show that nicotine induces the expression of galectin–3 (an anti–apoptotic β–galactoside–binding lectin) in breast cancer cell line and in primary tumors from breast cancer patients. Galectin–3 or its upstream signaling molecule STAT3 or α9nAChR could be a potential...Read More